Carnegie

Summary

Carnegie appeared to be the Corporate Investor, which was created in 1803. The fund was located in Europe if to be more exact in Sweden. The leading representative office of defined Corporate Investor is situated in the Stockholm.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Corus Pharma. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Pharmaceutical, Biotechnology.

The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Carnegie, startups are often financed by Kleiner Perkins, JPMorgan Partners (JPMP), Chrysalix Venture Capital. The meaningful sponsors for the fund in investment in the same round are WestRiver Group, LLC, Washington State University, SunAmerica Ventures.

The important activity for fund was in 2004. The higher amount of exits for fund were in 2006. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Carnegie works on 4 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Carnegie the average startup value is 50-100 millions dollars.